MCHRI News & Updates
6th Annual MCHRI Symposium - Recordings Available
Thank you to those of you who joined us in-person for the 6th Annual MCHRI Symposium! It was a change to bring together faculty, trainees, students, and postdocs to explore the latest developments and innovations in maternal and child health research. Recordings of all sessions are now available.
Monday, December 11, 2023, 12pm-1pm
Grand Rounds Room in CAM or Online via Zoom
Understanding and Manipulating Immune Modulation by the Microbiome
Join the MCHRI seminar to learn about new efforts to stimulate the immune system using bacteria that live in the gut and on the skin.
Speaker:
Michael Fischback, PhD, Professor, Bioengineering
Monday, January 29, 204, 12pm-1pm
Red Oak Room in CAM or Online via Zoom
Geopolitical Unrest: How Aid Sanctions Impact Global Progress on Maternal and Child Health
Political unrest and armed conflict are increasing with aid sanctions being the most common tool to respond to certain types of political events. Aid sanctions are a unique tool of statecraft previously thought not to impact the humanitarian population. This research seminar explores findings of how aid sanctions impact maternal and child health in fragile nations. Join Professor Paul Wise and Dr. Ruth Gibson for a conversation about protecting MCH during political unrest and how sanctions might be used to protect principles of international law while minimizing harm to local populations.
Speaker:
Ruth Gibson, PhD, Postdoctoral Scholar, Center for Innovation in Global Health, Medicine
Paul Wise, MD, MPH, Professor, Pediatrics, Neonatal and Developmental Medicine
Stanford Medicine News
-
Old immune systems revitalized in Stanford Medicine mouse study, improving vaccine response
Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Stanford Medicine researchers were able to revitalize the immune system in mice.
-
Stanford Medicine-designed AI tools tackle soft tissue sarcomas, identify new treatment strategies
Soft tissue sarcomas are rare and difficult to treat. Machine-learning tools designed at Stanford Medicine uncover distinct cellular communities that correlate with prognosis, immunotherapy success.
-
Stanford Medicine invests more than $1 billion in local communities
Stanford Medicine invested $1.07 billion in funds and services during the 2023 fiscal year to bolster Bay Area communities.